First step of many big steps...While we wait...(for the new people on this board).
In this link(paid advertising)....
.
Pharma stock Theralase paves way for in-home cancer treatment | 2024-08-21 | Investing News | Stockhouse It said...
'' Rutherrin has been shown to be effective across numerous potential applications, including:
-Bladder Cancer.
-Cancer Immunotherapy.
-Chemotherapy.
-Non-Small Cell Lung Cancer.
-Numerous Virus Including The Coronavirus.
Now the pharma stock(TLT) is solidifying these multi-billion-dollar addressable markets...Theralase also notes that because Rutherrin and Metformin both cross the blood-brain barrier,as well as tumour-specific blood barriers, their combination potentially allows Rutherrin to target cancer cells anywhere in the body'' You can easily see that Ruvidar approval is just the very first step, of
many multi-billion-dollard steps. I love the short-term and long-term potential of TLT.
.